Evidence mapPaperPMID 42029608Full record

ArticleMedical sciences (Basel, Switzerland)2026

Supervised (Home-Based Exercise) Prehabilitation Program in Pancreatic Cancer Patients Undergoing to Neoadjuvant Chemotherapy: A Pilot Feasibility Study.

Gennaro Boccia, Luca Beratto, Cantor Tarperi, Alberto Rainoldi, Chiara Calliera, Daniele Ierace, Maria Antonietta Satolli, Simona Bo, Paola Costelli

Abstract read
In one paragraph

Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gennaro BocciaDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy.ORCID 0000-0001-8706-4098
Luca BerattoDepartment of Medical Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0002-8479-0067
Cantor TarperiDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37124 Verona, Italy.ORCID 0000-0002-7208-9484
Alberto RainoldiDepartment of Medical Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0003-4553-2898
Chiara CallieraDepartment of Anesthesiology and Critical Care, AOU Città della Salute e della Scienza, 10126 Torino, Italy.
Daniele IeraceDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Maria Antonietta SatolliDepartment of Oncology, University of Torino, 10126 Torino, Italy.
Simona BoDepartment of Medical Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0001-6862-8628
Paola CostelliDepartment of Clinical and Biological Sciences, University of Torino, 10043 Orbassano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with pancreatic cancer (PC) commonly present with reduced aerobic fitness, sarcopenia, and malnutrition, which may increase perioperative risk and compromise access to chemotherapy treatments. Although exercise-based prehabilitation can improve physical fitness, its implementation is often limited by short diagnostic-to-surgery intervals and treatment-related toxicity.

methodsWe conducted a pilot prospective pretest-posttest feasibility study in Torino, Italy. Patients with PC undergoing neoadjuvant chemotherapy prior to surgery were offered a 4-week, partially supervised, home-based bimodal exercise prehabilitation program (single-arm design) combining remotely monitored high-intensity interval training (HIIT) on a cycle ergometer with functional and resistance exercises. The primary outcome was adherence to prescribed exercise frequency, intensity, and duration, objectively assessed via remote monitoring. Secondary outcomes included cardiorespiratory fitness (CPET), muscle function, body composition, fatigue, quality of life, and circulating inflammatory markers.

resultsFrom July 2022 to February 2024, 23 patients were screened; 15 were eligible and 10 enrolled. Four participants discontinued the intervention (two due to asthenia/fatigue, one due to chemotherapy-related adverse events, and one for organizational reasons), leaving six participants who completed the program. Among completers, fatigue and quality of life did not change meaningfully. Aerobic capacity and muscle function outcomes were generally stable, with few pre-post changes exceeding the minimum clinically important difference (MCID) thresholds used. Body composition markers and the assessed circulating cytokines/chemokines remained unchanged except for IL-6 levels, which decreased significantly (

conclusionsA partially supervised, home-based HIIT-based prehabilitation program is feasible for a subset of PC patients undergoing neoadjuvant therapy, but a substantial attrition rate suggests the need for more flexible symptom-adapted prescriptions and enhanced supportive strategies.

Indexed as

Exercise TherapyNeoadjuvant TherapyPancreatic NeoplasmsPreoperative ExerciseAgedFeasibility StudiesFemaleHigh-Intensity Interval TrainingHumansMaleMiddle AgedPilot ProjectsProspective StudiesQuality of Lifecardiopulmonary exercise testingfeasibilityHIIThome-based exercisepancreatic cancerprehabilitation

Identifiers

PMID42029608
PMCPMC13108150

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.